Lack of Association of the APOL1 G3 Haplotype in African Americans with ESRD.

Apolipoprotein L1 gene (APOL1) G1 and G2 variants are strongly associated with progressive nondiabetic nephropathy in populations with recent African ancestry. Selection for these variants occurred as a result of protection from human African trypanosomiasis (HAT). Resequencing of this region in 10 genetically and geographically distinct African populations residing in HAT endemic regions identified eight single nucleotide polymorphisms (SNPs) in strong linkage disequilibrium and comprising a novel G3 haplotype. To determine whether the APOL1 G3 haplotype was associated with nephropathy, G1, G2, and G3 SNPs and 70 ancestry informative markers spanning the genome were genotyped in 937 African Americans with nondiabetic ESRD, 965 African Americans with type 2 diabetes-associated ESRD, and 1029 non-nephropathy controls. In analyses adjusting for age, sex, APOL1 G1/G2 risk (recessive), and global African ancestry, the G3 haplotype was not significantly associated with ESRD (P=0.05 for nondiabetic ESRD, P=0.57 for diabetes-associated ESRD, and P=0.27 for all-cause ESRD). We conclude that variation in APOL1 G3 makes a nominal, if any, contribution to ESRD in African Americans; G1 and G2 variants explain the vast majority of nondiabetic nephropathy susceptibility.

[1]  C. Rotimi,et al.  Evolution of the primate trypanolytic factor APOL1 , 2014, Proceedings of the National Academy of Sciences.

[2]  Nicholette D. Palmer,et al.  Gene-gene interactions in APOL1-associated nephropathy. , 2014, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[3]  John D Reveille,et al.  End‐Stage Renal Disease in African Americans With Lupus Nephritis Is Associated With APOL1 , 2014, Arthritis & rheumatology.

[4]  Barry I. Freedman,et al.  APOL1 risk variants, race, and progression of chronic kidney disease. , 2013, The New England journal of medicine.

[5]  J. Kopp.  JC viruria and kidney disease in APOL1 risk genotype individuals: is this a clue to a gene × environment interaction? , 2013, Kidney international.

[6]  Felicia Gomez,et al.  Identifying Darwinian selection acting on different human APOL1 variants among diverse African populations. , 2013, American journal of human genetics.

[7]  M. Rocco,et al.  JC polyoma virus interacts with APOL1 in African Americans with non-diabetic nephropathy , 2013, Kidney international.

[8]  M. Beggs,et al.  Apolipoprotein L1 risk variants associate with systemic lupus erythematosus-associated collapsing glomerulopathy. , 2013, Journal of the American Society of Nephrology : JASN.

[9]  G. Genovese,et al.  APOL1 variants and kidney disease in people of recent African ancestry , 2013, Nature Reviews Nephrology.

[10]  B. Astor,et al.  Apolipoprotein L1 gene variants associate with hypertension-attributed nephropathy and the rate of kidney function decline in African Americans , 2012, Kidney international.

[11]  C. Langefeld,et al.  Polymorphisms in MYH9 are associated with diabetic nephropathy in European Americans. , 2012, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[12]  A. Ashley-Koch,et al.  MYH9 and APOL1 are both associated with sickle cell disease nephropathy , 2011, British Journal of Haematology.

[13]  Giulio Genovese,et al.  APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy. , 2011, Journal of the American Society of Nephrology : JASN.

[14]  A. Köttgen,et al.  The MYH9/APOL1 region and chronic kidney disease in European-Americans. , 2011, Human molecular genetics.

[15]  Jasmin Divers,et al.  A genome-wide association study for diabetic nephropathy genes in African Americans. , 2011, Kidney international.

[16]  C. Winkler,et al.  Association of Trypanolytic ApoL1 Variants with Kidney Disease in African Americans , 2010, Science.

[17]  S. Rosset,et al.  Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 gene , 2010, Human Genetics.

[18]  Thomas Meitinger,et al.  Genome-wide linkage analysis of serum creatinine in three isolated European populations. , 2009, Kidney international.

[19]  P. Donnelly,et al.  A Flexible and Accurate Genotype Imputation Method for the Next Generation of Genome-Wide Association Studies , 2009, PLoS genetics.

[20]  D. Vlahov,et al.  MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis , 2008, Nature Genetics.

[21]  Manuel A. R. Ferreira,et al.  PLINK: a tool set for whole-genome association and population-based linkage analyses. , 2007, American journal of human genetics.

[22]  P. Donnelly,et al.  A new multipoint method for genome-wide association studies by imputation of genotypes , 2007, Nature Genetics.

[23]  Hua Tang,et al.  Estimation of individual admixture: Analytical and study design considerations , 2005, Genetic epidemiology.

[24]  D. Vlahov,et al.  APOL 1 Genetic Variants in Focal Segmental Glomerulosclerosis and HIV-Associated Nephropathy , 2011 .